NS Wind Down Co Inc. (NSTGQ)

OTCMKTS: NSTGQ · Delayed Price · USD
0.0715
-0.0035 (-4.67%)
Jun 24, 2024, 3:35 PM EDT - Market closed
Market Cap 3.44M
Revenue (ttm) 162.47M
Net Income (ttm) -166.43M
Shares Out 48.12M
EPS (ttm) -3.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 303,701
Open 0.0675
Previous Close 0.0750
Day's Range n/a
52-Week Range 0.0400 - 5.1800
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About NSTGQ

NS Wind Down Co., Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data fro... [Read more]

Sector Healthcare
IPO Date Jun 26, 2013
Employees 550
Stock Exchange OTCMKTS
Ticker Symbol NSTGQ
Full Company Profile

Financial Performance

In 2022, NSTGQ's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021.

Financial Statements

News

Seattle biotech company NanoString to be acquired by Bruker for $392M, ending bankruptcy process

NanoString announced Wednesday that it will be acquired by Bruker, ending the company's restructuring process that included a Chapter 11 bankruptcy plan.

Other symbols: BRKR
2 months ago - GeekWire

NanoString Technologies to Be Acquired by Bruker Corporation

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announced that substan...

2 months ago - Business Wire

NanoString Products Drive Breakthrough Cancer Research at the 2024 American Association of Cancer Research (AACR) Conference

SEATTLE--(BUSINESS WIRE)-- #AACR24--NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, will present at the 2024 meeting of the American A...

2 months ago - Business Wire

Healthcare investment firm Patient Square Capital agrees to acquire NanoString assets for $220M

NanoString, the Seattle-based biotech company that initiated a Chapter 11 bankruptcy process last month, announced late Sunday it agreed to a deal with healthcare investment firm Patient Square Capita...

3 months ago - GeekWire

Patient Square Capital, a Leading Health Care-Focused Investment Firm, Agrees to Acquire NanoString Technologies

SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString” or the “Company”), a leading provider of life science tools for discovery and translational research, tod...

3 months ago - Business Wire

European UPC Court of Appeal Overturns Injunction Impacting NanoString's CosMx Products, Company to Immediately Resume Sales in 16 EU Countries

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (OTC: NSTGQ) (“NanoString”), a leading provider of life science tools for discovery and translational research, today announced that the Europea...

4 months ago - Business Wire

NanoString Announces Completion of Financing to Support Restructuring Process

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the Company has entered into ...

4 months ago - Business Wire

NanoString stock sinks 70% as Seattle biotech company enters bankruptcy process

Seattle-based publicly traded biotech company NanoString Technologies announced Monday that it has initiated a Chapter 11 bankruptcy plan and is exploring a potential sale in the latest fallout from i...

5 months ago - GeekWire

NanoString Takes Steps to Restructure Its Business and Protect Its Mission to Map the Universe of Biology

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG) (“NanoString” or “the Company”), a leading provider of life science tools for discovery and translational research, today announc...

5 months ago - Business Wire

NanoString Launches the CosMx 6,000 plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

SEATTLE--(BUSINESS WIRE)-- #AGBT2024--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the commercial av...

5 months ago - Business Wire

NanoString's CosMx SMI Achieves Whole Transcriptome Imaging at Single-Cell Resolution

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the release of the first publ...

6 months ago - Business Wire

NanoString Technologies to cut 9% of workforce, gets delisting notice from Nasdaq

Seattle-based publicly traded biotech company NanoString Technologies said in a filing Friday that it plans to cut about 50 positions, or 9% of its workforce.

6 months ago - GeekWire

NanoString Reports Inducement Grants Under Nasdaq Listing Rules

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock ...

6 months ago - Business Wire

NanoString to Webcast Presentation from 42nd Annual J.P. Morgan Healthcare Conference

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is sch...

6 months ago - Business Wire

NanoString stock sinks nearly 50% after losing patent lawsuit case against 10x Genomics

Shares of Seattle-based publicly traded biotech company NanoString Technologies fell nearly 50% to an all-time low on Monday following its loss in a patent infringement case against 10x Genomics.

Other symbols: TXG
7 months ago - GeekWire

NanoString Comments on Delaware District Court Verdict

SEATTLE--(BUSINESS WIRE)--NanoString Comments on Delaware District Court Verdict.

7 months ago - Business Wire

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

Jury Awards 10x Genomics Over $31 Million in Damages and Finds All Seven Asserted Patents Valid and Willfully Infringed by NanoString GeoMx Decision is Third Ruling Against NanoString, Showing Serial ...

Other symbols: TXG
7 months ago - PRNewsWire

NanoString Technologies to Present Portfolio of Cutting-edge Brain Research and Novel Spatial Biology Applications for Neuroscience

SEATTLE--(BUSINESS WIRE)--NanoString will present at the Society for Neuroscience meeting new brain research powered by its spatial profiling and spatial imaging platforms.

8 months ago - Business Wire

NanoString to Webcast Presentations from Upcoming Healthcare Conferences

SEATTLE--(BUSINESS WIRE)--NanoString to present at November conferences.

8 months ago - Business Wire

NanoString Technologies Releases Operating Results for Third Quarter of 2023

SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString reports Q3 2023 Operating Results.

8 months ago - Business Wire

NanoString Customers Present First Data Using the Most Comprehensive Spatial Proteomics Panel Available

SEATTLE--(BUSINESS WIRE)--NanoString Technologies, a leading provider of life sciences tools for discovery and translational research, announced today the line-up of researchers joining NanoString at ...

8 months ago - Business Wire

10x Genomics Comments on Second UPC Preliminary Injunction Decision

UPC Denies Second Preliminary Injunction Request; Prior Injunctions Against NanoString's CosMx Products in Europe Remain in Full Effect PLEASANTON, Calif. , Oct. 10, 2023 /PRNewswire/ -- 10x Genomics,...

Other symbols: TXG
9 months ago - PRNewsWire

NanoString Provides Preliminary Financial and Operational Highlights for Third Quarter of 2023

SEATTLE--(BUSINESS WIRE)-- #earnings--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financi...

9 months ago - Business Wire

A*STAR's Genome Institute of Singapore, NanoString and Next Level Genomics Establish Joint Lab to Advance Studies of Complex Diseases with Spatial Genomics

SINGAPORE--(BUSINESS WIRE)--A*STAR's Genome Institute of Singapore (GIS), NanoString® Technologies, Inc. (NASDAQ: NSTG), and Next Level Genomics (NLG), today announced the establishment of a joint lab...

9 months ago - Business Wire

10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

Second Injunction Issued Against CosMx PLEASANTON, Calif. , Sept. 19, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the Europ...

Other symbols: TXG
9 months ago - PRNewsWire